Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Subscribe
    • Home
    • Top Stories
    • Business
    • Tech
    • Companies
    • Events
    • Announcements
    Home»Uncategorized»Showa Denko Announces 2021 2Q Consolidated Financial Results
    Uncategorized

    Showa Denko Announces 2021 2Q Consolidated Financial Results

    Marie JonesBy Marie JonesAugust 10, 2021No Comments1 Min Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    TOKYO, Aug 10, 2021 – (JCN Newswire) – Showa Denko K.K. (SDK; TSE:4004) today announced its 2021 2Q consolidated financial results.

    2021 Second Quarter Consolidated Financial Statements and Summary
    – https://www.sdk.co.jp/assets/files/english/ir/library/fss2021-2q.pdf

    About Showa Denko K.K.

    Showa Denko K.K. (SDK; TSE:4004, ADR:SHWDY) is a major manufacturer of chemical products serving from heavy industry to computers and electronics. The Petrochemicals Sector provides cracker products such as ethylene and propylene, the Chemicals Sector provides industrial, high-performance and high-purity gases and chemicals for semicon and other industries, the Inorganics Sector provides ceramic products, such as alumina, abrasives, refractory/graphite electrodes and fine carbon products. The Aluminum Sector provides aluminum materials and high-value-added fabricated aluminum, the Electronics Sector provides HD media, compound semiconductors such as ultra high bright LEDs, and rare earth magnetic alloys, and the Advanced Battery Materials Department (ABM) provides lithium-ion battery components. For more information, visit www.sdk.co.jp/english/.

    Contact:
    Showa Denko K.K., IR Office, Finance & Accounting Department, Tel: 81-3-5470-3323

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleElegance Optical subscribes 50% of the enlarged issued share capital of the Target Company for China’s Yantai Liquefied Natural Gas (LNG) Terminal Project investment
    Next Article AMDL, a Subsidiary of China Biotech Services, is Exclusively Licensed to Distribute FDA Approved Lung & Colon Cancer Companion Diagnostic Assay in Several Asian Regions Including China

    Related Posts

    JCB and Krungsriayudhya Card Launch the Krungsri JCB Ultimate Credit Card

    October 19, 2026

    TANAKA to Provide Medals Expressing the Exhilaration of All Participants and the Event’s Excitement for the Tokyo Legacy Half Marathon 2026

    October 8, 2026

    JCB Launches Premium Card Issuing Initiative for Affluent Customers in ASEAN Under Strategic Comprehensive Partnership with MUFG Bank

    October 6, 2026
    Add A Comment

    Comments are closed.

    Latest News

    • GA-ASI Partnering With Spirit Defense For FQ-42 CCA Production
    • Study Finds Lower Rates of Overweight Among Vegan-Fed Cats
    • Savills Hong Kong Hosts Grand Reception to Celebrate 40th Anniversary, Over 300 Guests Gather to Mark Glorious Milestone
    • ASN 2026: HighTide Therapeutics Presents New HTD1801 Data Highlighting Therapeutic Potential in Chronic Kidney Disease
    • MicroVision Begins Commercial Production of MOVIA(TM) Pro for Superior Short-Range Sensing and Onboard Perception, Enabling Physical AI at the Edge
    • New Global Initiative Seeks to Modernize Health Workforce Mobility
    • P&G, Nestle, Mars, AstraZeneca, ITC and Bekaert win OMP Supply Chain Awards
    • Zhipu, Jiangmen, QuantGroup and Other Investors Join Forces to Back RMB 1 Billion Cognitive Intelligence Venture Capital Fund for Physical AI Ecosystem Development
    • Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027
    • Chervon Appoints Stephen Sarnocinski to President – End User Research, Sales and Service – OPE Commercial Landscaping Market Global
    © 2026 BusinessNewsAsia.com
    • About Us
    • Contact Us
    • BusinessNews.ph
    • AsiaPEVC.com
    • DevFiNews.com
    • RenewableEnergy.ph

    Type above and press Enter to search. Press Esc to cancel.